CVS HEALTH Corp Q3 FY2026 results
$89.35−0.49%
CVS HEALTH Corp reported revenue of $108.4 billion, up 5.4% from a year earlier, net income of $2.17 billion and diluted earnings per share of $1.68 against −$3.13 for the third quarter of fiscal 2026 (the three months to 30 Sep 2026).
From its quarterly report, filed 4 Nov 2026. Compiled and checked by AapWire.
Q3 FY2026 against Q3 FY2025
Three months to 30 Sep 2026, against the three months to 30 Sep 2025. Amounts in USD.
| Measure | Q3 FY2026 | Q3 FY2025 | Change |
|---|---|---|---|
| Revenue | $108.4B | $102.9B | +5.4% |
| Operating income | $3.57B | −$3.21B | — |
| Operating margin | 3.3% | −3.1% | +6.4 pts |
| Net income | $2.17B | −$3.98B | — |
| Diluted EPS | $1.68 | −$3.13 | — |
| Operating cash flow | $4.72B | $796.0M | +493% |
| Capital expenditure | $817.0M | $698.0M | +17.0% |
| Free cash flow | $3.91B | $98.00M | +3887% |
Operating KPIs for the quarter
| KPI | Q3 FY2026 | Change on a year |
|---|---|---|
| Total same store sales (change on a year) | −0.6% | down 14.9 points |
| Pharmacy same store sales (change on a year) | −0.6% | down 17.4 points |
| Same store sales (Front store · change on a year) | −0.6% | down 2.1 points |
| Same store sales (Prescription volume · change on a year) | 3.9% | down 5.0 points |
| Health Care Benefits medical membership | 26.1M | down 2.2% |
| Products revenue | $69.2B | up 7.2% |
| Services revenue | $4.0B | up 0.8% |
| Health Services revenue | $54.0B | up 9.5% |
| Health Care Benefits revenue | $36.9B | up 2.4% |
| Pharmacy & Consumer Wellness revenue | $35.5B | down 2.0% |
Earlier quarters
| Quarter | Period end | Revenue | Change on a year | Diluted EPS |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sep 2026 | $108.4B | +5.4% | $1.68 |
| Q2 FY2026 | 30 Jun 2026 | $106.1B | +7.3% | $2.31 |
| Q1 FY2026 | 31 Mar 2026 | $100.4B | +6.2% | $2.30 |
| Q4 FY2025 | 31 Dec 2025 | $105.7B | +8.2% | $2.29 |
| Q3 FY2025 | 30 Sep 2025 | $102.9B | +7.8% | −$3.13 |
| Q2 FY2025 | 30 Jun 2025 | $98.92B | +8.4% | $0.80 |
| Q1 FY2025 | 31 Mar 2025 | $94.59B | +7.0% | $1.41 |
| Q4 FY2024 | 31 Dec 2024 | $97.71B | +4.2% | $1.30 |
More on CVS HEALTH Corp: financial statements · revenue · earnings per share
CVS's results, as they are filed.
Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.
